Faruqi and Faruqui, LLP Logo
Share this page

Surgical Care Affiliates, Inc. (SCAI)

NASDAQ:SCAI

Summary

Faruqi & Faruqi, LLP Announces the Investigation of Surgical Care Affiliates, Inc. (SCAI) Over the Proposed Sale of the Company to UnitedHealth Group Incorporated

Nadeem Faruqi, founding partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Surgical Care Affiliates, Inc. (“Surgical Care” or the “Company”) (NASDAQ:SCAI) for potential breaches of fiduciary duties in connection with the sale of the Company to Optum, a leading health services company and part of UnitedHealth Group Incorporated (“UnitedHealth”) for approximately $2.3 billion in a cash and stock transaction.

The Company’s stockholders will only receive $57.00 for each share of Company common stock they own. The Company’s stockholders will receive between 51 percent and 80 percent of the offer in UnitedHealth common stock and the remainder in cash.

If you own common stock in Surgical Care and wish to obtain additional information and protect your investments free of charge, please fill out the form below or contact Nadeem Faruqi, Esq. either via e-mail at nfaruqi@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330.  You may also contact Juan E. Monteverde, Esq.  either via email at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Request Information

Please tell us about yourself by completing the form below and we will provide you with additional
information at no cost to you on how to join the Class Action.

  • Company:
    Surgical Care Affiliates, Inc. (SCAI)
  •    

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

Nadeem Faruqi
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330

Email:

Case Details

Date:

  • 01/13/2017

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.